Pharma Industrial India - Professional magazine for pharma industry suppliers and lab technology

NEWS ABOUT >

Biotechnology

Clean Rooms

Clinical Trials

Consultants

Digitalization

Drug Discovery & Development

Engineering

Global Pharma

Industrial talks

Ingredients

Lab Equipment

Logistics & Distribution

Manufacturing

Market

Outsourcing

Packaging

Quality / GMP

Regulation

Safety

Last edition

All magazines
Subscribe to our magazine

News about "anti-tumour immune responses"

Agenus Wins First Global Approvals for Botvymo and Evamplix

Armenia has authorised botensilimab and balstilimab for adults with previously treated microsatellite-stable metastatic colorectal cancer without active liver metastases.

Anti-tumour Immune Responses | 12/10/2026 | By News Bureau | 232

Evogene's Biomica Signs Global Licensing Deal with Lishan Biotech for Microbiome-Based Cancer Therapy BMC128

Lishan Biotech secures exclusive worldwide rights to develop and commercialise BMC128, a Phase I microbiome-based immunotherapy candidate showing early promise in lung and renal cancers.

Anti-tumour Immune Responses | 07/02/2026 | By News Bureau | 242

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members